Physician profile
Daniel Talamo
NPI 1780030742
$8,837.15
in general payments reported to CMS, 2019-2025
38 companies · $1,293 in 2025
The $1,293 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $28.93 · 2021: $91.92 · 2022: $3,041 · 2023: $1,916 · 2024: $2,352 · 2025: $1,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,561.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,561.54 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $1,125.11 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Boston Scientific Corporation | $1,000.08 | 2021-2025 | Cryoablation Needles, Icefx Cryoablation System, Avista Mri |
| Abbott Laboratories | $729.98 | 2022-2025 | Proclaim, Confirm Rx, Freestyle Libre 3 |
| Lucid Diagnostics INC. | $504.65 | 2022 | |
| Lilly USA, LLC | $448.83 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Medtronic, INC. | $434.81 | 2023-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Grt US Holding, INC. | $400.12 | 2022 | |
| Amgen INC. | $264.81 | 2023-2025 | Otezla, Prolia, Krystexxa |
| Organon LLC | $223.54 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $218.08 | 2019-2025 | Jardiance, Synjardy |
| Angiodynamics, INC. | $197.34 | 2023 | Auryon Laser System 100-120 Vac |
| Cleerly, INC. | $192.57 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Nevro Corp. | $178.63 | 2022-2024 | Senza |
| Stryker Corporation | $160.52 | 2023 | Mako |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $147.42 | 2024 | Arexvy, Shingrix |
| Orthalign INC | $147.08 | 2023 | Orthalign Plus |
| Bayer Healthcare Pharmaceuticals INC. | $133.07 | 2020-2024 | |
| Procept Biorobotics Corporation | $124.05 | 2022 | |
| Dynavax Technologies Corporation | $115.60 | 2022 | |
| Biotronik INC. | $76.92 | 2023 | Pulsar-18 T3 |
| Dexcom, INC. | $76.65 | 2025 | Dexcom G6 Transmitter |
| Nalu Medical, INC. | $37.31 | 2023-2024 | Nalu Neurostimulation System |
| Bardy Diagnostics, INC. | $36.65 | 2022 | |
| Bioventus LLC | $36.65 | 2022-2023 | Supartz Fx Sodium Hyaluronate |
| Pfizer INC. | $34.83 | 2025 | |
| Covis Pharma Gmbh | $27.45 | 2022 | |
| Integra Lifesciences Corporation | $25.52 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Orthofix Medical, INC. | $22.95 | 2025 | Physio-Stim |
| Avanos Medical | $22.79 | 2023 | |
| Solventum Corporation | $20.25 | 2024 | Activ.A.C. |
| Vericel Corporation | $19.72 | 2023 | Maci |
| Inspire Medical Systems, INC. | $18.85 | 2024 | Inspire |
| Advanced Oxygen Therapy INC. | $18.11 | 2025 | Topical Oxygen Chamber For Extremities |
| Hologic Sales and Service, LLC | $15.46 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.54 | 2022 | |
| Shield Therapeutics INC | $13.26 | 2024 | |
| Impulse Dynamics (USA) INC. | $12.41 | 2025 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Talamo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.